腹腔镜肝切除术治疗肝内胆管结石病患者临床疗效研究*

doi:10.3969/j.issn.1672-5069.2023.01.032

实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (1): 124-127.doi: 10.3969/j.issn.1672-5069.2023.01.032

腹腔镜肝切除术治疗肝内胆管结石病患者临床疗效研究^*

尹秋实, 王学国, 宋奇锋

570100 海口市海南医学院第一附属医院肝胆胰外科(尹秋实,宋奇锋);第二附属医院肝胆胰外科(王学国)

收稿日期:2022-04-20 出版日期:2023-01-10 发布日期:2023-02-07
通讯作者: 宋奇锋,E-mail:1057872686@qq.com
作者简介:尹秋实,男,37岁,医学硕士,副主任医师。E-mail:yqsmyth@163.com
基金资助:
^*海南省自然科学基金基础与应用研究计划项目(编号:821RC707)

Clinical efficacy of laparoscopic hepatectomy in the treatment of patients with intrahepatic bile duct stones

Yin Qiushi, Wang Xueguo, Song Qifeng

Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Hainan Medical College, Haikou 570100, Hainan Province, China

Received:2022-04-20 Online:2023-01-10 Published:2023-02-07

摘要/Abstract

摘要： 目的比较先行腹腔镜肝切除(LH)还是先行胆总管切开取石治疗肝内胆管结石病(IHC)患者的临床效果。方法 2017年1月～2021年10月我院诊治的IHC患者90例,其中合并胆总管结石79例。在53例A组,先行LH术,再行胆总管切开取石,在37例B组先行胆总管切开取石再进行LH,随访6个月。结果 A组手术时间、术后引流管拔除时间和术后住院日分别为(226.1±45.3)min、(7.1±1.8)d和(8.0±1.5)d,显著短于B组【分别为(294.5±58.8)min、(8.4±2.0)d和(9.7±2.4)d,P<0.05】,术中出血量为(215.4±39.7)ml,也显著少于B组【(328.2±37.2)ml,P<0.05】;术前术后两组血清ALT、AST、ALP和TBIL水平无显著性差异(P>0.05);随访3个月,两组术后切口感染、腹腔积液、胆漏、胆道出血和胆管炎并发症发生率比较,差异无统计学意义(13.2%对 24.3%,P>0.05);随访6个月,A组结石复发率为5.7%,与B组的8.1%比,差异无统计学意义(P>0.05)。结论对于合并胆总管结石的IHC患者是先行LH还是先行胆总管切口取石可能不影响治疗效果,而需要根据患者腹腔情况作出选择。外科医生需要总结经验,给出合理的手术路径,以提高手术效率和治疗结果。

关键词: 肝内胆管结石病, 腹腔镜肝切除术, 胆总管切除取石, 治疗

Abstract: Objective The aim of this study was to compare the clinical efficacy of first laparoscopic hepatectomy (LH) and thereafter common bile duct incision for stone removal, or vice versa in the treatment of patients with intrahepatic bile duct stones (IHBDS). Methods 90 patients with IHBDS were enrolled in our hospital between January 2017 and October 2021, and the 53 patients in group A received first LH and thereafter common bile duct incision for stone removal and 37 patients in group B received first common bile duct incision for stone removal and thereafter LH. All patients were followed-up for six months. Results The surgical time, postoperative drainage tube removal and postoperative hospital stay in group A were(226.1±45.3)min, (7.1±1.8)d and (8.0±1.5)d, all significantly shorter than [(294.5±58.8)min, (8.4±2.0)d and (9.7±2.4)d, respectively, P<0.05], and intraoperative blood loss was (215.4±39.7)ml, also significantly less than [(328.2±37.2)ml, P<0.05] in group B; there were no significant differences as respect to blood biochemical parameters between the two groups at presentation and 5 days after operation(P>0.05); at the end of three month follow-up, the incidences of post-operational complications, such as incision infection, ascites, bile leakage, biliary bleeding and cholangitis between the two groups were not significantly different(13.2% vs. 24.3%, P>0.05); at the end of six month follow-up, the stone recurrence rates were not statistically significant between the two groups (5.7% vs 8.1%, P>0.05). Conclusion The first LH and thereafter common bile duct incision for stone removal, or vice versa in the treatment of patients with IHBDS could not lead to a different outcomes of patients, and the surgeons might make the decisions based the patients' conditions. We vigorously recommend them to summarize the clinical experiences to give out the indications.

Key words: Intrahepatic bile duct stones, Laparoscopic hepatectomy, Common bile duct incision for stone removal, Therapy

尹秋实, 王学国, 宋奇锋. 腹腔镜肝切除术治疗肝内胆管结石病患者临床疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 124-127.

Yin Qiushi, Wang Xueguo, Song Qifeng. Clinical efficacy of laparoscopic hepatectomy in the treatment of patients with intrahepatic bile duct stones[J]. Journal of Practical Hepatology, 2023, 26(1): 124-127.

参考文献

[1] 段昌虎,刘晓晨,段建峰.肝部分切除联合胆肠吻合术治疗肝内胆管结石患者疗效比较研究.实用肝脏病杂志,2022,25(1):112-115.
[2] 刘颖斌,陈炜.肝内胆管结石外科治疗的要点与难点.中华消化外科杂志,2020,19(8):808-812.
[3] 潘树波,吴春利,侯辉,等.基于倾向性评分匹配的开腹和LH治疗肝左叶胆管结石的队列研究.中华外科杂志,2020,58(7):530-538.
[4] Yao D, Wu S. Application of laparoscopic technique in the treatment of hepatolithiasis. Surg Laparosc Endosc Percutan Tech, 2020, 31(2):247-253.
[5] Liao KX, Chen L, Ma L, et al. Laparoscopic middle-hepatic-vein-guided anatomical hemihepatectomy in the treatment of hepatolithiasis: a 10-year case study. Surg Endosc, 2022, 36(2):881-888.
[6] 中华医学会外科学分会胆道外科学组.肝胆管结石病诊断治疗指南.中华消化外科杂志,2007,7(2):156-160.
[7] Dilek ON, Atasever A, Acar N, et al. Hepatolithiasis: clinical series, review and current management strategy. Turk J Surg, 2020, 36(4):382-392.
[8] Tao H, Wang P, Sun B, et al. One-step multichannel percutaneous transhepatic cholangioscopic lithotripsy applied in bilateral hepatolithiasis. World J Surg, 2020, 44(5):1586-1594.
[9] Liu J, Xu J, Luo D, et al. Long-term efficacy and advantages of minimally invasive hepatectomy for hepatolithiasis: a protocol for systematic review and meta-analysis. Medicine (Baltimore), 2020, 99(50):23230-23239.
[10] Öztürk A, Sönmez MG, Bakdik S, et al. Ultra-mini percutaneous hepatolithotomy in patients with large and multiple hepatolithiasis. Surg Laparosc Endosc Percutan Tech, 2020, 31(1):76-84.
[11] Li EL, Yuan RF, Liao WJ, et al. Intrahepatic bile duct exploration lithotomy is a useful adjunctive hepatectomy method for bilateral primary hepatolithiasis: an eight-year experience at a single centre. BMC Surg, 2019, 19(1):16-30.
[12] Xia H, Meng X, Xin X, et al. Resection of extrahepatic bile ducts with partial hepatectomy for treating intra- and extrahepatic hepatolithiasis. BMC Surg, 2021, 21(1):420-442.
[13] 史海军,张日欣,宁纯民.规则性肝叶切除治疗复杂性肝内胆管结石患者疗效研究.实用肝脏病杂志,2021,24(4):585-588.
[14] Kim J, Cho JY, Han HS, et al. Validation of a difficulty scoring system for laparoscopic liver resection in hepatolithiasis. Surg Endosc, 2021, 35(3):1148-1155.
[15] Yin X, Luo D, Huang Y, et al. Advantages of laparoscopic left hemihepatectomy: a meta-analysis. Medicine (Baltimore), 2019, 98(23):15929-15943.
[16] Assis BS, Coelho FF, Jeismann VB, et al. Total laparoscopicvs. open liver resection: comparative study with propensity score matching analysis. Arq Bras Cir Dig, 2020, 33(1):1494-1506.
[17] 何少武,吴波,徐洁,等.解剖性肝切除联合术中胆道镜治疗复杂肝内胆管结石的疗效分析.中华肝胆外科杂志,2019,25(9):681-684.
[18] Wang H, Lu W, Yang G, et al. Safety and feasibility analysis of combination therapy of laparoscopic left hepatectomy and choledochoscopy for calculus of the left intrahepatic duct. Minerva Chir, 2019, 74(2):115-120.
[19] Chen S, Huang L, Qiu FN, et al. Total laparoscopic partial hepatectomy versus open partial hepatectomy for primary left-sided hepatolithiasis: a propensity, long-term follow-up analysis at a single center. Surgery, 2018, 163(4):714-720.
[20] Shu J, Wang XJ, Li JW, et al. Robotic-assisted laparoscopic surgery for complex hepatolithiasis: a propensity score matching analysis. Surg Endosc, 2019, 33(8):2539-2547.

腹腔镜肝切除术治疗肝内胆管结石病患者临床疗效研究^*

Clinical efficacy of laparoscopic hepatectomy in the treatment of patients with intrahepatic bile duct stones

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	黄晓铨, 陈世耀. 重视规范化处理门静脉高压并发食管胃静脉曲张出血^*[J]. 实用肝脏病杂志, 2023, 26(1): 1-3.
[2]	申艳, 陈琳. 内镜治疗食管胃静脉曲张破裂出血及其长期管理^*[J]. 实用肝脏病杂志, 2023, 26(1): 8-10.
[3]	张丹, 江建新. 重组细胞因子基因衍生蛋白与干扰素α-2b分别联合恩替卡韦治疗HBeAg阳性慢性乙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 27-30.
[4]	李苏苏, 董媛, 贾浩延, 秦颖. 门冬氨酸鸟氨酸联合结肠透析治疗肝性脑病患者疗效及其对血浆β-EP和LPS的影响^*[J]. 实用肝脏病杂志, 2023, 26(1): 75-78.
[5]	戴欢, 李凯, 朱永湘, 王超. 内镜下套扎和注射硬化剂治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 87-90.
[6]	丁海斌, 张欣, 李雅, 聂磊, 常柏玲, 王颖栋. TACE序贯微波消融联合索拉非尼治疗大肝细胞癌患者临床疗效研究[J]. 实用肝脏病杂志, 2023, 26(1): 108-111.
[7]	彭雨, 李海涛, 杨文丽, 余意. PD-1抑制剂联合仑伐替尼治疗老年中晚期原发性肝癌患者临床疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 112-115.
[8]	东贤进, 苏伟, 李连生, 谢智, 高军林. 腹腔镜肝切除术与开腹肝切除术治疗肝内胆管细胞癌患者短期临床疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 120-123.
[9]	张福, 陈俊卯, 梁晓辉. LCBDE术一期缝合治疗胆总管结石患者效果研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 128-131.
[10]	刘颂航, 高友逵, 曹良启. LC联合ERCP治疗胆囊结石合并肝外胆管结石患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(1): 132-135.
[11]	张子侠, 李德林, 张国梁. RFA联合益脾养肝方治疗原发性肝癌患者临床疗效观察[J]. 实用肝脏病杂志, 2023, 26(1): 142-144.
[12]	韩芳, 李佳峥, 南月敏. 肝硬化并发急性肾损伤诊治进展[J]. 实用肝脏病杂志, 2022, 25(6): 768-771.
[13]	李向阳, 丁光伟, 靳铭. 恩替卡韦治疗慢性乙型肝炎合并NAFLD患者临床疗效研究^*[J]. 实用肝脏病杂志, 2022, 25(6): 776-779.
[14]	吴凤萍, 崔丹丹, 王怡恺, 李梅, 刘晨瑞, 南希, 贾晓黎, 党双锁. 血清BAFF预测聚乙二醇干扰素-α治疗非活动性HBsAg携带者临床治愈的效能分析^*[J]. 实用肝脏病杂志, 2022, 25(6): 780-783.
[15]	许海玲, 秦刚, 薛红, 章颖. 艾尔巴韦/格拉瑞韦治疗基因1b型慢性丙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2022, 25(6): 788-791.